As per a peer-reviewed Lancet study, the efficacy of covaxin is 77.8%
The interim results of a Phase 3 study of Covaxin, an Indian vaccine developed by Bharat Biotech and the Indian ...
The interim results of a Phase 3 study of Covaxin, an Indian vaccine developed by Bharat Biotech and the Indian ...
© 2024 The Edge Media All Rights Reserved.
© 2024 The Edge Media All Rights Reserved.